Vaccinia virus is the prototypic member of the orthopoxviruses and replicates within the cytoplasm of the host cell. The 185-kb genome consists of a linear double-stranded DNA with covalently linked "hairpin" termini and has a coding potential for greater than 150 proteins (3, 9, 25) . Early genes are expressed before the onset of DNA replication, and the mRNAs are transcribed, capped, and 3' polyadenylated by virally encoded enzymes packaged within the virion (2, 22, 43) . Early gene transcripts, which are generally monocistronic, are terminated downstream of a 3' transcriptional termination sequence (TTTTTNT) (15) . Cycloheximide, a potent inhibitor of protein synthesis, is commonly used to cause arrest of the infectious cycle, so that only early mRNAs are synthesized. Late gene expression begins at the onset of DNA replication and requires the previous expression of the early proteins. Progression into the late phase of the infectious cycle can be blocked by inhibitors of DNA synthesis, such as cytosine arabinoside (CAR) or hydroxyurea. Late transcripts differ from early transcripts in that in general they do not have a discrete 3' transcription termination signal and are therefore heterogeneous in size and lack discrete 3' ends (6, 18) . Besides containing the usual 5' cap and 3' poly(A) tail, late transcripts also contain a 5' poly(A) tract that precedes the encoded transcript (1, 32) . The initiation of late transcription usually occurs within the conserved hexanucleotide, TAAATPu, and it is thought that the 5' polyadenylation results from slippage of the RNA polymerase during the transcription initiation process (8, 31) . Recently, a third, intermediate-early class of mRNA has been described, whose transcription is dependent on DNA replication but that, unlike late transcripts, does not depend on continuing protein synthesis (41) . * Corresponding author.
After the synthesis of late proteins, morphogenesis leads to mature virion production. Morphogenesis and the proteolytic processing of virus products can be interrupted by the addition of rifampin (21, 26) , leading to the accumulation of precursor proteins.
The vaccinia virus hemagglutinin (HA) is a glycoprotein found on both the cytoplasmic membrane of infected cells and the envelope of extracellular virus (26, 27) . The HA gene is nonessential, in that viruses not expressing a functional HA product are viable in cell culture. The HA gene, like many other nonessential genes, has been used as a site for insertion of foreign DNA for construction of vaccinia virus expression vectors (34, 39) . The HA gene has been considered a prototype for a strongly expressed nonstructural late gene in vaccinia virus. HA activity, as measured by the hemagglutination of chicken erythrocytes, is first detected at about 6 h postinfection, a time somewhat later than that seen for most other late genes (usually about 4 h postinfection) (30) . However, our work indicates that the HA gene product appears early in the infectious cycle and is expressed from two separate promoters, one functioning early and a second active only late in infection.
MATERIALS AND METHODS
Cells and viruses. Wild-type vaccinia virus (IHD-J strain) and rabbitpox virus (Utrecht strain) were obtained from the American Type Culture Collection. HeLa and CV-1 cells were maintained as monolayers on Eagle minimal essential medium (GIBCO F-11) supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 U of penicillin per ml, 100 ,ug of streptomycin per ml, and 0.1 mg of sodium pyruvate per ml.
Antisera. Monospecific anti-HA rabbit antiserum was generously provided by Sam Dales and has been described previously by Shida and Dales (37) .
VACCINIA VIRUS HEMAGGLUTININ 3599
Preparation of cell membranes. Plasma membranes were isolated from infected and uninfected cells by the two-phase polymer method of Brunette and Till (5) as modified by Weintraub and Dales (44) . Plasma membranes were prepared for immunoblots as described below.
Preparation of infected and uninfected cell extracts for immunoblots. Confluent monolayers of HeLa cells (4 x 107 cells per 150-mm dish) were infected at a multiplicity of infection (MOI) of 10 PFU of purified virus per cell. The inhibitors CAR (50 ,ug/ml) and rifampin (100 ,g/ml), used where indicated, were present throughout the infection.
Cells were harvested at the appropriate time postinfection by scraping into medium and then centrifuging at 800 x g for 5 min at 4°C. The cell pellets or purified plasma membranes were suspended in 0. (40) . Electrophoretic transfer was carried out at 250 mA for 3 h at 4°C in transfer buffer (25 mM Tris-HCl, 192 mM glycine, 20% methanol [pH 8.6]). After transfer was complete, the blots were blocked with a solution of 5% bovine serum albumin and 10% fetal bovine serum in PBS for 90 min at room temperature with agitation. The immunoblots were then washed in Tris-buffered saline (TBS; 10 mM Tris-HCl, 150 mM NaCl [pH 8.0]) and then incubated with the primary antibody overnight at room temperature with moderate agitation. The primary antibody was removed, and the blots were washed three times in TBS for 15 min per wash at room temperature, with moderate agitation. The blots were then incubated with the secondary antibody (goat anti-rabbit affinity-purified immunoglobulin G conjugated to alkaline phosphatase [Cooper/ Cappell]) diluted 1:2,000 in TBS. The blots were incubated for 90 min at room temperature, with agitation. The secondary antibody was removed, and the blots were then washed three times with TBS at room temperature for 15 min each wash. The blots were then developed using a freshly prepared solution of Nitro Blue Tetrazolium (50 mg/ml in 70% dimethylformamide in water) and 5-bromo-4-chloro-3-indolyl phosphate (50 mg/ml in 100% dimethylformamide), diluted 1:15 and 1:30, respectively, in 100 mM Tris (pH 9.5)-100 mM NaCl-5 mM MgCl2. Finally, the blots were transferred to a solution of 100 mM Tris-HCl (pH 7.0)-10 mM EDTA to stop the development and allowed to air dry.
Virus and DNA purification. Vaccinia virus IHD-J was purified from infected cells by the method of Moyer and Rothe (24) . DNA was prepared from purified virus suspended at 2 x 1011 PFU/ml in 10 mM Tris-HCl (pH 8.0)-100 mM NaCl-1% SDS-5 mM EDTA. Proteinase K (Boehringer Mannheim Biochemicals) was added to 250 ,ug/ml, and the suspension was incubated for 1 h at 37°C before extraction with an equal volume of phenol-chloroform (1:1) three times and chloroform once. DNA was precipitated from the aqueous phase with ethanol and dissolved in 10 mM Tris-HCl (pH
Vaccinia virus RNA. HeLa cells were infected at MOI of 10. Early viral RNA was prepared from cells infected for 4 h in the presence of cycloheximide (100 ,ug/ml). Late viral RNA was prepared from cells harvested at 18 h postinfection in the absence of inhibitors.
RNA was isolated from cells as described by Cox (7). Cells were washed twice with PBS and then lysed with 6 ml of 6 M guanidinium isothiocyanate in 0.1 M sodium acetate (pH 5.0) per 150-mm dish. The lysate from each dish was passed through a 20-gauge needle twice and through a 22-gauge needle once and then layered onto a 2-ml cushion of 5.7 M CsCl and centrifuged at 36, (19) and visualized by autoradiography.
RNA sequencing was performed as for primer extension, except that an appropriate dideoxynucleoside triphosphate was added to each of four separate reactions. The deoxynucleotide triphosphate/dideoxynucleotide triphosphate ratios in each termination reaction were 5.5, 1.4, 1.4, and 2.7 for T, A, G, and C reactions, respectively.
Construction of recombinant viruses. Recombinant vaccinia virus containing the E. coli xanthine-guanine phosphoribosyl transferase (gpt) gene was constructed by a method modified from that of Mackett et al. (17) . The recombinant virus was selected by using mycophenolic acid resistance as described by Boyle et al. (4) and Falkner et al. (10) . CV-1 cells (5 x 106 cells) in 60-mm dishes were infected with vaccinia virus IHD-J at an MOI of 0.05. At 2 h postinfection, the medium was removed and the cells were transfected with a mixture of 10 ,ug each of calcium phosphate-precipitated plasmid DNA and vaccinia virus genomic DNA. After 30 min of incubation at room temperature, 5 ml of culture medium was added, and the cells were incubated at 37°C. After 3 h of incubation, the culture medium was removed and replaced with fresh medium containing 2.5 jig of mycophenolic acid per ml, 15 ,ug of hypoxanthine per ml, and 250 ,ug of xanthine per ml; the culture was then incubated at 37°C for an additional 48 h. Confluent monolayers of CV-1 that had been pretreated with mycophenolic acid (2.5 p,g/ml) for 12 h were infected with virus from the transfections. After incubation for 2 h, infected monolayers were overlaid with gpt selection medium (GIBCO F-11, 5% fetal bovine serum, 2.5 ,ug of mycophenolic acid per ml, 15 jig of hypoxanthine per ml, and 250 ,ug of xanthine per ml) containing 1% purified agar (Oxoid). After 2 days of incubation at 37°C, the cells were stained with neutral red (GIBCO) to visualize plaques.
Plasmid DNA clones. pHGN-1 is pUC18 containing a 1.8-kb Sall-HindIII fragment including the HA gene derived from the right end of the HindIII A fragment of vaccinia virus IHD-J (3a, 34). Plasmid pTK61-gpt contains the E. coli gpt gene fused to the vaccinia virus early-late P7.5 promoter as a 2.1-kb EcoRI fragment (eco-gpt) (10) .
Plasmid pHA535 contains a 535-bp HpaII DNA fragment from pHGN-1. This insert fragment spans from position 622 of the HA coding sequence to 212 bp downstream of the HA translation stop codon (34) . The 535-bp insert was subcloned into XbaI-restricted pBluescript KS(+), after both ends of the vector and the insert were flushed with the E. coli DNA polymerase I large fragment and dNTPs, and then blunt end ligated with T4 DNA ligase (New England BioLabs). pHA535-gpt was constructed by inserting the 2.1-kb eco-gpt DNA fragment into the unique XbaI restriction site of pHA535 by blunt end ligation.
RESULTS
Expression of the vaccinia virus IHD-J HA in infected cells. In agreement with earlier studies (14) , we have found that the appearance of the HA protein as measured by the ability of infected cell extracts to agglutinate chicken erythrocytes is first detectable about 6 to 7 h postinfection (data not shown). These observations are consistent with the sugges-U 2 3 4 5 6 7 8 10 12 14 16 Through use of anti-HA polyclonal sera, we examined protein blots derived from cell extracts isolated at various times postinfection (Fig. 1) . We detected two immunoreactive protein species of 85 and 68 kDa. The 85-kDa protein can be detected as early as 2 h postinfection, whereas the 68-kDa protein is not observed before 5 h postinfection ( Fig.  1 ) even if gels are overloaded. Control lanes in which virus and cells were mixed and immediately lysed before electrophoresis were negative for the 85-and 68-kDa proteins, even with 10-fold more virus than was used for the kinetic analysis (Fig. 1, lanes 0 and V) . This demonstrated that the early appearance of the 85-kDa protein was not derived from HA contamination of the infecting virus.
The detection of a stable 68-kDa protein by the anti-HA serum was unexpected, since the only previously reported mature form of the HA has been a protein of 85 kDa (27, 36) . To show that the two proteins are derived from the same gene, we insertionally inactivated the HA gene, which eliminates both the 85-and 68-kDa proteins (data not shown).
The rapid appearance of the 85-kDa HA protein within 2 h postinfection is consistent with expression of an early protein (Fig. 1) Fig. 2A, lane  A) , but that the presence of CAR selectively blocks the appearance of the 68-kDa form of HA (Fig. 2A, lane B) . In cell extracts of HeLa cells infected with rabbitpox virus, an orthopoxvirus which fails to express hemagglutination activity, neither form of HA is detectable (Fig. 2A, lanes C and  D) . The lack of any immunoreactive proteins in rabbitpox virus-infected cells is again consistent with the 85-and 68-kDa proteins originating from the HA gene.
In an attempt to explore further the relationship between the two forms of HA, we also examined the effect of CAR and rifampin on the accumulation of the two HA proteins in total cell extracts. Synthesis of the 68-kDa form of HA is selectively inhibited by either CAR or rifampin (Fig. 2B) (Fig. 3A) . Double digestion of the HindIII-SalI fragment with AccI and XbaI releases a 904-bp fragment, derived entirely from within the putative HA ORF (Fig. 3A) , which we have used as a probe for Northern blots (Fig. 3B) . A discrete 1.65-kb transcript is detected in cells infected in the presence of cycloheximide (Fig. 3B, lane 4C) as well as early in a normal infection (lanes 2 and 3) , particularly when gels are overexposed (data not shown). We have compared the level of the 1.65-kb early HA transcript relative to that of the viral thymidine kinase, a known early gene (Fig. 3C) . Densitometric evaluation suggests the 1.65-kb transcript is present at approximately 20% of the level observed for the thymidine kinase mRNA. Later in a normal infection, HA mRNA becomes heterogeneous in size, consistent with the production of 3' polydisperse transcripts late in infection (Fig. 3B, lanes 4 through 18) . These results tentatively suggest that an early transcript encompasses the HA coding region, which is consistent with the early appearance of a protein recognized by the anti-HA serum. However, the 1.65-kb early transcript may be derived from the DNA strand complementary to the HA coding strand. Even allowing for the addition of 3' poly(A), the 945-bp coding sequence of HA is much smaller than the 1.65 kb observed for the early transcript. The HA early mRNA may therefore be dicistronic and fused to the upstream or downstream ORF. We have addressed these questions with the use of strandspecific RNA probes. Labeled RNA transcripts within the HA, complementary to the HA, and from the adjacent upstream and downstream coding regions were prepared from cloned RsaI fragments in pBluescript KS(+) by using T7 or T3 promoters (Fig. 4A) .
No hybridization occurs to either early or late mRNA from probe A, which was designed to measure activity from the strand complementary to that which encodes the HA protein (Fig. 4B, panel A) . Sense probes from both the downstream (p17) and HA ORFs hybridize to a 1.65-kb early mRNA (Fig. 4B, panels B and C) , whereas probe D, measuring transcription from the sense strand of the upstream p16 ORF, hybridizes to a larger 1.75-kb mRNA (Fig. 4B,  panel D) Within this intervening sequence, there are five translation stop codons found in the same reading frame. Therefore, cotranslation of the HA and p17 ORFs, which theoretically could generate a 58-kDa protein, is not likely, unless the intervening sequence between the two ORFs is spliced or edited so as to bypass all five potential termination codons.
We have addressed the possibility of cotranslation of the HA and p17 ORFs by engineering an early transcription termination signal just downstream of the HA ORF, so that during transcription an mRNA containing sequences solely from the HA ORF can be obtained. This has been achieved by taking advantage of an XbaI site just downstream of the HA ORF to insert the eco-gpt fragment (the 2.1-kb EcoRI fragment of pTK61-gpt). At one end of this inserted fragment is an early transcription termination (TTTTTAT) signal, which through the cloning process is placed just downstream of the HA coding sequence (Fig. 5A) , between the HA and p17 ORFs. The recombinant virus (IHD-J: :HA535-gpt) should synthesize an artificially truncated HA transcript containing only sequences from the HA ORF (Fig. 5A) . If the HA product is actually a fusion protein of the HA and p17 ORFs, then this mutant should produce either no HA or a truncated HA protein.
The recombinant vaccinia virus IHD-J::HA535-gpt synthesizes a 1.2-kb early HA transcript that is truncated compared with that of the wild-type virus (Fig. SB, lanes E) , as expected. This suggests that the wild-type 1.65-kb transcript encompasses both the HA ORF and the downstream p17 ORF. An analysis of the HA protein synthesized by this mutant (Fig. 6) shows that the HA protein is indistinguishable from that found during wild-type vaccinia virus IHD-J infection; i.e., both the 68-and 85-kDa proteins are synthesized in the absence of any inhibitors, whereas in the presence of CAR the synthesis of the 68-kDa HA is blocked and that of the 85-kDa HA is expressed at a reduced level but to the same extent as for wild-type virus in the presence of CAR (Fig. 6) . We conclude that the HA and p17 ORFs, while normally cotranscribed in wild-type virus, are not cotranslated as a fusion protein.
5'-end analysis of HA gene transcripts. Our data suggest that HA expression occurs throughout the entire infectious cycle and that the HA product is not solely a late protein as previously thought. We analyzed the kinetics and location of the HA promoter(s) through primer extension. A 30-mer oligonucleotide, hybridizing to nucleotides 67 to 38 of the HA ORF, was synthesized and used to map the 5' end(s) of the HA transcript(s). Our results suggest an unusually complex mode of transcription. A single transcription start site is A IHD-J lfA-ORF p detected for early viral transcripts (Fig. 7A , lane E), whereas this site is joined by a second site later in infection that is approximately 150 bp upstream of the early site (Fig. 7A,  lane L) . Transcripts beginning at the early start site are also detected at late times during infection. The second start site is referred to as a late promoter because it is detected only during the late stage of viral infection. This experiment suggests that the HA gene is regulated by two promoters, an We have sequenced the 5' ends of the HA transcripts to map precisely the transcriptional start sites. The results indicate that the early transcriptional start site is found at the -7 position relative to the translational AUG start site, whereas that of the late transcriptional start site is 135 bases upstream at position -142 (Fig. 7B) . The 5' poly(A) sequences typically present in late viral transcripts are apparent.
The sequence around the putative HA ORF AUG translation initiation site is shown in Fig. 8 . The transcriptional start site for the late message is found within the AAA of the sequence TAAATG (boxed sequence, Fig. 8 ), which is thought to function as a transcriptional start site for other late genes (31) . The HA translational start site (Fig. 8) Fig. 8 ). These minicistrons could potentially encode peptides of 4 and 3 amino acids, respectively. The start site for the early promoter is within 10 bp of the putative HA translational start site (Fig. 8) . 
DISCUSSION
We have detected two forms (85 and 68 kDa) of the HA protein that are produced during vaccinia virus IHD-J infection (Fig. 1) . Although an HA-related protein of 68 kDa has been described previously, earlier reports suggested that the 68-kDa HA is a transient, partially glycosylated, intermediate form of the protein readily detectable only in certain mutants or when infections were carried out in the presence of inhibitors of N glycosylation such as tunicamycin (35, 36, 38) . Evidence that both the 68-and 85-kDa proteins described here are derived from the HA gene is provided by the cross-reactivity of both proteins with anti-HA sera ( Fig. 1  and 2 ), the disappearance of both proteins when the HA coding sequence is interrupted by insertional inactivation (unpublished results), and the absence of both proteins in rabbitpox virus-infected cells (Fig. 2A) .
Standard biological assays for hemagglutinating activity suggest that the HA first appears late in infection at about 6 h, yet with immunoblots we can detect the 85-kDa form of the HA protein early in infection (Fig. 1) . The simplest explanation for this apparent discrepancy is probably related to the relative insensitivity of the biological assay for HA activity in contrast to the very sensitive immunoblot assays. In the presence of rifampin, only the 85-kDa form of HA is found (Fig. 2B ), yet hemagglutinating activity may be readily assayed in infected cells (14, 44) , suggesting that this form rather than the 68-kDa protein is responsible for most of the observed HA activity. The failure to observe the 68-kDa Our results with the recombinant virus IHD-J: :HA535-gpt indicate that both the 85-and 68-kDa HA-related proteins are derived from the 945-bp HA ORF. The in vitro translation product of HA mRNA, with an apparent size of 58 kDa (38) , presumably results from aberrant migration on SDSpolyacrylamide gels.
Although the HA gene was originally thought to be solely a late gene, we have shown that HA expression occurs throughout the viral cycle through the action of two promoters; i.e., an early promoter and a late promoter (Fig. 7) . The early site of transcription initiation is at the -7 position (relative to the translational AUG start codon) of the HA ORF ( Fig. 7B and 8 ) and apparently leads to synthesis of a 1.65-kb dicistronic HA transcript containing the HA ORF and the adjacent downstream p17 ORF as well (Fig. 4B) . Despite the fact that the HA and p17 ORFs are probably cotranscribed, engineering of a transcription signal directly downstream of the HA ORF, resulting in monocistronic HA transcripts, has no effect on HA expression (Fig. 6) . Transcripts starting at the early promoter are found early and late in infection (Fig. 7A) (Fig. 8) . These minicistrons have been noted in both viral and eukaryotic transcripts (12, 13, 29) . The presence of minicistrons is thought to downregulate gene expression at the level of translation by decreasing the accessibility of the ATG of the downstream main ORF, thus resulting in a decreased rate of protein synthesis (28, 33) . Regulation of gene expression in poxvtruses is commonly believed to be primarily transcriptional, although regulation at the translational level has been proposed (32) . The iiiinicistrons in the late HA transcripts of vaccinia virus could provide an additional mechanism for the translational regulation of gene expression in poxviruses, a possibility which we are in the process of investigating.
